Chongqing Baiya Sanitary Products Co., Ltd. specializes in the production and distribution of high-quality sanitary products. As a key player in the hygiene and personal care sector, the company focuses on manufacturing items such as sanitary napkins, diapers, and other related products designed to meet personal hygiene needs. Leveraging advanced technology and rigorous quality control measures, Chongqing Baiya aims to ensure the comfort and safety of its consumers. The company serves a broad market, including both domestic and international clientele, with its wide array of sanitary solutions. Operating from its base in Chongqing, China, Chongqing Baiya Sanitary Products Co., Ltd. contributes significantly to the hygiene industry by addressing essential consumer requirements and maintaining high standards in product effectiveness and sustainability. Its role in the financial market is underscored by its commitment to innovation and meeting evolving market demands, thus establishing itself as a trusted brand in the sanitary products landscape.
Industry
Household & Personal Products
Consumer Defensive sector · China
Stories
Structural patterns identified in Chongqing Baiya Sanitary Products Co., Ltd.
No stories identified yet.
Key Metrics
Market Capitalization
8.05BCNY
NormalMar 18, 2026
Trailing P/E
27.47CNY
NormalMar 18, 2026
Revenue (TTM)
3.55BCNY
NormalMar 18, 2026
Forward Yield
11.75%
Annual Rate
CNY 2.20
Paid annual
Payout Ratio
80.9%
Moderate
Loading dividend history...
Track Record
Frequency
Annual
Payback Period
31.9 yr
Years to recoup investment via dividends alone
Upcoming
Ex-Dividend Date
Apr 23, 2025
Valuation9
Market Capitalization
8.05BCNY
NormalMar 18, 2026
Enterprise Value
7.46BCNY
NormalMar 18, 2026
Trailing P/E
27.47CNY
Coordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination
Profit Margin
8.27%
Normal
Mar 18, 2026
Beta
0.8680CNY
NormalMar 18, 2026
52-Week Change
-22.64CNY
ExtremeMar 18, 2026
Forward Annual Dividend Yield
11.75%
AboveNormalMar 18, 2026
Normal
Mar 18, 2026
Forward P/E
18.22CNY
NormalMar 18, 2026
PEG Ratio
18.22CNY
ExtremeMar 18, 2026
Price to Sales (TTM)
2.26CNY
NormalMar 18, 2026
Price to Book (MRQ)
5.47CNY
NormalMar 18, 2026
Enterprise to Revenue
2.10CNY
NormalMar 18, 2026
Enterprise to EBITDA
19.85CNY
NormalMar 18, 2026
Profitability & Growth54
Gross Margin
53.14%
NormalMar 18, 2026
Profit Margin
8.27%
NormalMar 18, 2026
Operating Margin
7.86%
NormalMar 18, 2026
Return on Assets (TTM)
0.0961CNY
NormalMar 18, 2026
Return on Equity (TTM)
0.2049CNY
NormalMar 18, 2026
Revenue (TTM)
3.55BCNY
NormalMar 18, 2026
Revenue per Share (TTM)
8.23CNY
NormalMar 18, 2026
Quarterly Revenue Growth
0.0830CNY
NormalMar 18, 2026
Gross Profit (TTM)
1.87BCNY
NormalMar 18, 2026
EBITDA
343.62MCNY
ExtremeMar 18, 2026
Net Income (TTM)
293.72MCNY
NormalMar 18, 2026
Quarterly Earnings Growth (YoY)
-0.0390CNY
NormalMar 18, 2026
Operating Cash Flow (TTM)
257.96MCNY
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
16.98MCNY
NormalMar 18, 2026
Forward Annual Dividend Rate
2.20CNY
NormalMar 18, 2026
Forward Annual Dividend Yield
11.75%
AboveNormalMar 18, 2026
Trailing Annual Dividend Rate
0.5500CNY
NormalMar 18, 2026
Trailing Annual Dividend Yield
2.94%
NormalMar 18, 2026
Payout Ratio
0.8088CNY
NormalMar 18, 2026
Revenue
3.25B
NormalFY2024 · Dec 31, 2024
Cost of Goods Sold
1.52B
NormalFY2024 · Dec 31, 2024
Gross Profit
1.73B
NormalFY2024 · Dec 31, 2024
Operating Income
316.87M
NormalFY2024 · Dec 31, 2024
Pre-tax Income
339.06M
NormalFY2024 · Dec 31, 2024
Income Tax Expense
51.39M
NormalFY2024 · Dec 31, 2024
Net Income
287.67M
NormalFY2024 · Dec 31, 2024
EBIT
340.09M
NormalFY2024 · Dec 31, 2024
ebitda-income
401.12M
NormalFY2024 · Dec 31, 2024
Research & Development
72.12M
NormalFY2024 · Dec 31, 2024
Selling, General & Administrative
1.03B
NormalFY2024 · Dec 31, 2024
Other Operating Expenses
26.34M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Income
4.21M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Expense
1.03M
NormalFY2024 · Dec 31, 2024
EPS (Basic)
0.6700
NormalFY2024 · Dec 31, 2024
EPS (Diluted)
0.6700
NormalFY2024 · Dec 31, 2024
Basic Shares Outstanding
429.36MShares
NormalFY2024 · Dec 31, 2024
Diluted Shares Outstanding
429.36MShares
NormalFY2024 · Dec 31, 2024
Net Income from Continuing Operations
287.67M
NormalFY2024 · Dec 31, 2024
Minority Interests (P&L)
0.00
NormalFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00
NormalFY2024 · Dec 31, 2024
Operating Cash Flow
190.20M
NormalFY2024 · Dec 31, 2024
Free Cash Flow
174.22M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
389.67M
NormalFY2024 · Dec 31, 2024
Net Income (CF Statement)
287.67M
NormalFY2024 · Dec 31, 2024
Other Non-cash Items
1.45M
NormalFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
3.80M
NormalFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-102.72M
NormalFY2024 · Dec 31, 2024
Capital Expenditures
-150.99M
NormalFY2024 · Dec 31, 2024
Purchase of Investments
-520.00M
NormalFY2024 · Dec 31, 2024
Sale of Investments
626.11M
NormalFY2024 · Dec 31, 2024
Net Investing Cash Flow
-44.88M
NormalFY2024 · Dec 31, 2024
Common Dividends Paid
-235.92M
NormalFY2024 · Dec 31, 2024
Other Financing Charges
-1.26M
NormalFY2024 · Dec 31, 2024
Net Financing Cash Flow
-237.18M
NormalFY2024 · Dec 31, 2024
Financial Strength31
Shares Outstanding
429.65MShares
NormalMar 18, 2026
Float Shares
197.53MCNY
NormalMar 18, 2026
% Held by Insiders
0.6162CNY
NormalMar 18, 2026
% Held by Institutions
0.1381CNY
NormalMar 18, 2026
Total Cash (MRQ)
533.96MCNY
NormalMar 18, 2026
Total Cash per Share (MRQ)
1.24CNY
NormalMar 18, 2026
Total Debt (MRQ)
1.78MCNY
NormalMar 18, 2026
Total Debt to Equity (MRQ)
0.1210CNY
NormalMar 18, 2026
Current Ratio (MRQ)
2.18CNY
NormalMar 18, 2026
Book Value per Share (MRQ)
3.42CNY
NormalMar 18, 2026
Total Assets
2.15B
NormalFY2024 · Dec 31, 2024
Total Current Assets
1.33B
NormalFY2024 · Dec 31, 2024
Total Liabilities
701.22M
NormalFY2024 · Dec 31, 2024
Total Non-current Assets
823.07M
NormalFY2024 · Dec 31, 2024
Total Non-current Liabilities
62.73M
NormalFY2024 · Dec 31, 2024
Total Current Liabilities
638.49M
NormalFY2024 · Dec 31, 2024
Cash
389.67M
NormalFY2024 · Dec 31, 2024
Cash Equivalents
4.98M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents
394.66M
NormalFY2024 · Dec 31, 2024
Other Short-term Investments
332.41M
NormalFY2024 · Dec 31, 2024
Accounts Receivable
219.24M
NormalFY2024 · Dec 31, 2024
Inventory
283.41M
NormalFY2024 · Dec 31, 2024
Accounts Payable
309.48M
NormalFY2024 · Dec 31, 2024
Short-term Debt
27.59M
NormalFY2024 · Dec 31, 2024
Other Current Liabilities
9.84M
NormalFY2024 · Dec 31, 2024
Long-term Debt
4.18M
NormalFY2024 · Dec 31, 2024
Other Non-current Liabilities
3.54M
NormalFY2024 · Dec 31, 2024
Common Stock (Book)
429.32M
NormalFY2024 · Dec 31, 2024
Retained Earnings
603.31M
NormalFY2024 · Dec 31, 2024
Total Shareholders' Equity
1.45B
NormalFY2024 · Dec 31, 2024
Treasury Stock
5.24M
ExtremeFY2024 · Dec 31, 2024
Market & Technical9
52-Week Low
17.68CNY
NormalMar 18, 2026
52-Week High
34.99CNY
NormalMar 18, 2026
52-Week Change
-22.64CNY
ExtremeMar 18, 2026
Beta
0.8680CNY
NormalMar 18, 2026
50-Day MA
21.05CNY
NormalMar 18, 2026
200-Day MA
24.24CNY
NormalMar 18, 2026
Avg 10-Day Volume
6.23MCNY
NormalMar 18, 2026
Avg 30-Day Volume
5.65MCNY
NormalMar 18, 2026
Diluted EPS (TTM)
0.6800CNY
NormalMar 18, 2026
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.